Your browser doesn't support javascript.
loading
Physician Approaches to Antithrombotic Therapies for Recently Symptomatic Carotid Stenosis.
Ganesh, Aravind; Beland, Benjamin; Jewett, Gordon A E; Campbell, David J T; Varma, Malavika; Singh, Ravinder-Jeet; Al-Sultan, Abdulaziz; Wong, John H; Menon, Bijoy K.
Afiliação
  • Ganesh A; Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
  • Beland B; Department of Community Health Sciences, University of Calgary Cumming School of Medicine, Calgary, Canada.
  • Jewett GAE; The Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
  • Campbell DJT; Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
  • Varma M; Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
  • Singh RJ; The Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
  • Al-Sultan A; Department of Community Health Sciences, University of Calgary Cumming School of Medicine, Calgary, Canada.
  • Wong JH; Departments of Medicine and Cardiac Sciences, University of Calgary Cumming School of Medicine, Calgary, Canada.
  • Menon BK; Department of Emergency Medicine, University of Calgary Cumming School of Medicine, Calgary, Canada.
Can J Neurol Sci ; 51(2): 210-219, 2024 Mar.
Article em En | MEDLINE | ID: mdl-36803592
ABSTRACT

BACKGROUND:

Whereas the beneficial effect of antiplatelet therapy for recurrent stroke prevention has been well established, uncertainties remain regarding the optimal antithrombotic regimen for recently symptomatic carotid stenosis. We sought to explore the approaches of stroke physicians to antithrombotic management of patients with symptomatic carotid stenosis.

METHODS:

We employed a qualitative descriptive methodology to explore the decision-making approaches and opinions of physicians regarding antithrombotic regimens for symptomatic carotid stenosis. We conducted semi-structured interviews with a purposive sample of 22 stroke physicians (11 neurologists, 3 geriatricians, 5 interventional-neuroradiologists, and 3 neurosurgeons) from 16 centers on four continents to discuss symptomatic carotid stenosis management. We then conducted thematic analysis on the transcripts.

RESULTS:

Important themes revealed from our analysis included limitations of existing clinical trial evidence, competing surgeon versus neurologist/internist preferences, and the choice of antiplatelet therapy while awaiting revascularization. There was a greater concern for adverse events while using multiple antiplatelet agents (e.g., dual-antiplatelet therapy (DAPT)) in patients undergoing carotid endarterectomy compared to carotid artery stenting. Regional variations included more frequent use of single antiplatelet agents among European participants. Areas of uncertainty included antithrombotic management if already on an antiplatelet agent, implications of nonstenotic features of carotid disease, the role of newer antiplatelet agents or anticoagulants, platelet aggregation testing, and timing of DAPT.

CONCLUSION:

Our qualitative findings can help physicians critically examine the rationale underlying their own antithrombotic approaches to symptomatic carotid stenosis. Future clinical trials may wish to accommodate identified variations in practice patterns and areas of uncertainty to better inform clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Endarterectomia das Carótidas / Estenose das Carótidas / Acidente Vascular Cerebral Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Endarterectomia das Carótidas / Estenose das Carótidas / Acidente Vascular Cerebral Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article